ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 986

Integrated Comprehensive Analysis of Immune Cell Subsets and Serum Protein Profile Identifies the Role of Pre-Germinal Center B Cells in Sjogren’s Syndrome Pathogenesis

Yoshiaki Kassai1, Katsuya Suzuki2, Rimpei Morita3, Maiko Takiguchi1, Rina Kurisu1, Takahiro Miyazaki1, Akihiko Yoshimura3 and Tsutomu Takeuchi2, 1Inflammation Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Kanagawa, Japan, 2Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 3Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: B cells, Sjogren's syndrome and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Session Title: B cell Biology and Targets in Autoimmune Disease: Rheumatoid Arthritis and Related Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose Whole blood flow cytometric analysis and serum protein profiling were commonly utilized to characterize disease-specific alterations in a wide variety of autoimmune diseases. However, precise mechanisms underlying their pathophysiological conditions were still obscure because each experimental approach was carried out independently and not well integrated. Therefore, we performed comprehensive flow cytometric analysis by multi-colored staining in combination with serum protein profile to fully understand pathophysiological aspects in rheumatoid arthritis (RA) and primary Sjogren’s syndrome (pSS).

Methods Heparinized peripheral blood was collected from untreated RA patients (N = 51), pSS patients (N = 60), and healthy controls (N = 36). Fresh whole blood was immediately stained with fluorescent-labeled antibodies and analyzed with 3-laser, 8-color FACS equipment. Over a thousand of serum protein profile were also obtained with aptamer technology from SomaLogic, Inc. Serum immunoglobulin concentrations were evaluated by ELISA and gene expression levels were analyzed using quantitative real-time PCR.

Results Among over 40 immune cell subsets we investigated, surface IgD+ CD38++ B cells, called pre-germinal center B (pre-GC B), were significantly increased in both RA and pSS patients. Interestingly, serum IgG but not IgM and IgA was positively correlated with the number of pre-GC B cells in pSS but not RA, suggesting their distinct role in pSS pathogenesis. Consistent with this, GC-related serum proteins such as PD-L2, SLAMF2, and CD30 ligand were significantly elevated and correlated with pre-GC B in pSS but not RA. Furthermore, pre-GC B cells isolated from pSS patients exhibited higher GC-related gene expressions including XBP1 and BACH2 than those from healthy controls.

Conclusion Our findings suggest possible role of pre-GC B in pSS pathogenesis through IgG production and germinal center formation. By integrating multiple comprehensive analyses, we identified a novel immune cell phenotype, indicating this strategy as a useful tool to highly impact on better understanding of autoimmune diseases.


Disclosure:

Y. Kassai,

Takeda Pharmaceutical Company Limited,

3;

K. Suzuki,
None;

R. Morita,
None;

M. Takiguchi,

Takeda Pharmaceutical Company Limited,

3;

R. Kurisu,

Takeda Pharmaceutical Company Limited,

3;

T. Miyazaki,

Takeda Pharmaceutical Company Limited,

3;

A. Yoshimura,
None;

T. Takeuchi,

Abbott Japan Co., Ltd., Astellas Pharma, Bristol–Myers K.K., Chugai Pharmaceutical Co, Ltd., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Co., Pfizer Japan Inc., Sanofi–Aventis K.K., Santen Pharmaceutica,

2,

Abbott Japan Co., Ltd., Bristol–Myers K.K., Chugai Pharmaceutical Co,. Ltd., Eisai Co., Ltd., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Co., Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., Astellas Pharma, Daiichi Sankyo Co.,Ltd.,

8,

Astra Zeneca K.K., Eli Lilly Japan K.K., Novartis Pharma K.K., Mitsubishi Tanabe Pharma Co., Asahi Kasei Medical K.K., Abbvie GK, Daiichi Sankyo Co.,Ltd.,

5.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/integrated-comprehensive-analysis-of-immune-cell-subsets-and-serum-protein-profile-identifies-the-role-of-pre-germinal-center-b-cells-in-sjogrens-syndrome-pathogenesis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies